| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.589 | 3.886 | 1.904 | 4.643 | 4.552 | 1.443 | 3.251 | 3.999 | 3.681 | 3.707 |
| Total Income - EUR | 4.589 | 3.886 | 1.904 | 4.643 | 4.577 | 1.443 | 3.251 | 3.999 | 3.681 | 3.707 |
| Total Expenses - EUR | 2.155 | 2.042 | 1.844 | 2.820 | 3.180 | 1.668 | 1.336 | 1.380 | 1.780 | 870 |
| Gross Profit/Loss - EUR | 2.435 | 1.844 | 60 | 1.822 | 1.397 | -225 | 1.914 | 2.618 | 1.901 | 2.837 |
| Net Profit/Loss - EUR | 2.297 | 1.727 | 3 | 1.683 | 1.260 | -264 | 1.817 | 2.498 | 1.597 | 2.383 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Moldanmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.364 | 4.164 | 4.199 | 1.982 | 1.568 | 8 | 1.638 | 2.576 | 1.737 | 2.572 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.700 | 3.462 | 3.404 | 1.074 | 1.054 | 0 | 772 | 2.028 | 711 | 0 |
| Cash | 1.665 | 702 | 796 | 907 | 514 | 8 | 865 | 549 | 1.026 | 2.572 |
| Shareholders Funds | 2.351 | 4.054 | 3.989 | 1.735 | 1.310 | -215 | 1.607 | 2.547 | 1.646 | 2.431 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.013 | 110 | 211 | 247 | 258 | 223 | 31 | 29 | 92 | 141 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Moldanmed S.r.l.